Genen­ta is at­tempt­ing a rare biotech leap from Mi­lan to Wall Street

Pier­lui­gi Parac­chi, CEO and one of the trio of lead­ers run­ning gene ther­a­py biotech Genen­ta, has fre­quent­ly lament­ed the ab­sence of Ital­ian biotechs on Nas­daq …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER